At the IGTP TODAY

News

- Research

SNCA transcripts found in blood are candidate biomarkers for Lewy body dementia and Parkinson disease

In a new study published in the Journal of Molecular Science, the Genomics and Transcriptomics of Synucleinopathies Group, led by Dr Katrin Beyer, have got one step nearer to finding a reliable biomarker to differentiate between Lewy body dementia and Parkinson disease in the early stages, when symptoms are very similar. Correct diagnosis is extremely difficult, but essential for these patients as the wrong treatment can have very serious effects.

- Research

The Barcelona Medical Photonics Network: united to improve the health and well-being of society

As the research institute of the Germans Trias i Pujol Hospital, the IGTP is one of 8 health research institutes that has joined the ICFO to consolidate a state-of-the-art bench to bedside Barcelona Photonics Technology Network. The Medical Photonics Network of Barcelona was presented on 18 February, it aims to promote the research and development activities in photonics being carried out in the Barcelona area by formalizing the long-running relationship between the ICFO and its biomedical and clinical partners.

- Institutional

Can Ruti focuses on the effect of COVID-19 in the gender perspective in biomedical research to celebrate the International Day of Women and Girls in Science

The 3rd Celebration of the International Day of Women and Girls in Science at Can Ruti took place on Wednesday 10 February, organized by the multi-institutional working group "Women in Science (WiS)", and hosted by the IGTP. The symposium looked at data on the gender perspective of the effects of the Covid-19 pandemic presenting data from studies both on and off the campus and providing a platform for personal testimonies from men and women involved in research and healthcare.

- Campus Can Ruti, Research

Blocking the spread of HIV or favouring the spread of the tuberculosis bacteria, the flip side of the Siglec-1 protein's absence

In 2016, the Retrovirology and Clinical Studies group at IrsiCaixa discovered how the absence of the Siglec-1 protein, involved in modulating the immune system, blocks the spread of HIV throughout the body. Now, a study led by the same research group and the Experimental Tuberculosis Unit of the Germans Trias i Pujol Research Institute (IGTP) has shown that, on the other hand, this same deficiency favours the dissemination of Mycobacterium tuberculosis (Mtb), the tuberculosis-causing agent. 

- Research

A pilot study reveals that natural killer cells could track the progress of type 1 diabetes

The Immunology of Diabetes Group, led by Marta Vives-PI has shown that levels of 4 subtypes of natural killer (NK) cells in the blood of Type 1 Diabetes patients change through different stages of the disease. These cells have a complex role in the immune attack during T1D and have been implicated in both the destruction and protection of insulin-producing cells. This pilot study, published in Frontiers in Immunology, tracks the levels of 4 subtypes of NK cells and suggests that these cells are good candidate biomarkers for disease progression.

- Campus Can Ruti, Projects

8 health professionals from Germans Trias awarded Talents grants

The Talents Programme supports research projects in the health sector and despite the pandemic research into other diseases continues. 14 health professionals in all, and 8 of them from Germans Trias i Pujol, have been awarded grants to carry out research projects in the 2020 edition of the programme. The awards represent recognition for young health professionals who are carrying out research activities.

- Amics deCan Ruti

ECOMASC collects 6,250 euros for COVID-19 research at the IGTP

ECOMASC (Eco-masks) is playing its part in the battle against COVID-19. On 9 December the Moda Dstil shops of Catalonia presented a cheque for 6,250 euros to the Germans Trias I Pujol Research Institute (IGTP). ECOMASC has not only helped to prevent the propagation of the virus with its masks, but it has also made a generous gesture so that research can continue to look for solutions to COVID-19.